← FDA Drug Approvals (Drugs@FDA)

BYQLOVI

NDA · New Drug Application · Sponsor: HARROW EYE · Approved 2024-03-04

Drug application

FDA Application #

NDA218158

Application type

New Drug Application

Brand name

BYQLOVI

Generic name

CLOBETASOL PROPIONATE

Active ingredients

CLOBETASOL PROPIONATE

Dosage form

SUSPENSION/DROPS

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

HARROW EYE

Manufacturer

Eyenovia, Inc.

First approval

2024-03-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown